BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9644299)

  • 1. Serum hyaluronan as a marker of liver fibrosis in hemophiliacs with hepatitis C virus-associated chronic liver disease.
    Yamada M; Fukuda Y; Nakano I; Katano Y; Takamatsu J; Hayakawa T
    Acta Haematol; 1998; 99(4):212-6. PubMed ID: 9644299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hyaluronic acid reflects the effect of interferon treatment on hepatic fibrosis in patients with chronic hepatitis C.
    Yamada M; Fukuda Y; Koyama Y; Nakano I; Urano F; Katano Y; Hayakawa T
    J Gastroenterol Hepatol; 1996 Jul; 11(7):646-51. PubMed ID: 8840240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system.
    Ninomiya T; Yoon S; Hayashi Y; Sugano M; Kumon Y; Seo Y; Shimizu K; Kasuga M
    J Gastroenterol Hepatol; 1998 Jan; 13(1):68-74. PubMed ID: 9737575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C.
    Ishibashi K; Kashiwagi T; Ito A; Tanaka Y; Nagasawa M; Toyama T; Ozaki S; Naito M; Azuma M
    Hepatology; 1996 Jul; 24(1):27-31. PubMed ID: 8707274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
    Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
    Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
    Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
    Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection.
    Zöhrens G; Armbrust T; Meyer Zum Büschenfelde KH; Ramadori G
    Dig Dis Sci; 1994 Sep; 39(9):2007-13. PubMed ID: 8082511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan.
    Bentsen KD; Horn T; Risteli J; Risteli L; Engström-Laurent A; Hørslev-Petersen K; Lorenzen I
    Liver; 1987 Dec; 7(6):339-46. PubMed ID: 3437796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
    Wang T; Wang B; Liu X
    Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.
    McHutchison JG; Blatt LM; de Medina M; Craig JR; Conrad A; Schiff ER; Tong MJ
    J Gastroenterol Hepatol; 2000 Aug; 15(8):945-51. PubMed ID: 11022838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of interferon-treated chronic hepatitis C and serum hepatic fibrosis markers.
    Ueno T; Ide T; Hashimoto O; Uchimura Y; Torimura T; Kumashiro R; Inuzuka S; Sata M
    Hepatogastroenterology; 2001; 48(40):1124-8. PubMed ID: 11490815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C.
    Takeda T; Yasuda T; Nakayama Y; Nakaya M; Kimura M; Yamashita M; Sawada A; Abo K; Takeda S; Sakaguchi H; Shiomi S; Asai H; Seki S
    World J Gastroenterol; 2006 Dec; 12(48):7768-73. PubMed ID: 17203518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
    Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
    Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa-2A interferon.
    Gallorini A; Plebani M; Pontisso P; Chemello L; Masiero M; Mantovani G; Alberti A
    Liver; 1994 Oct; 14(5):257-64. PubMed ID: 7997085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of non-invasive serum markers for predicting liver fibrosis in Egyptian patients with chronic HCV infection.
    El Guesiry D; Moez P; Hossam N; Kassem M
    Egypt J Immunol; 2011; 18(2):1-12. PubMed ID: 23082465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha.
    Lebensztejn DM; Sobaniec-Lotowska ME; Kaczmarski M; Voelker M; Schuppan D
    World J Gastroenterol; 2006 Jun; 12(21):3338-43. PubMed ID: 16733849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum markers and pathological evaluation in hepatitis fibrosis of chronic hepatitis B treated with interferon alpha].
    Deng L; Zhou Y; Peng X; Deng H; Deng Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():66-7. PubMed ID: 11509145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.